Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

10x Genomics (TXG) Change in Intangibles (2019 - 2024)

10x Genomics' Change in Intangibles history spans 4 years, with the latest figure at $1.0 million for Q2 2024.

  • For Q2 2024, Change in Intangibles changed N/A year-over-year to $1.0 million; the TTM value through Sep 2025 reached $1.0 million, changed 0.0%, while the annual FY2024 figure was $1.0 million, 8.34% up from the prior year.
  • Change in Intangibles for Q2 2024 was $1.0 million at 10x Genomics, up from $200000.0 in the prior quarter.
  • Across five years, Change in Intangibles topped out at $1.0 million in Q2 2024 and bottomed at $200000.0 in Q3 2023.
  • The 3-year median for Change in Intangibles is $825000.0 (2020), against an average of $712500.0.
  • The largest YoY upside for Change in Intangibles was 3608.0% in 2020 against a maximum downside of 3608.0% in 2020.
  • A 3-year view of Change in Intangibles shows it stood at $927000.0 in 2020, then plummeted by 78.43% to $200000.0 in 2023, then surged by 400.0% to $1.0 million in 2024.
  • Per Business Quant, the three most recent readings for TXG's Change in Intangibles are $1.0 million (Q2 2024), $200000.0 (Q3 2023), and $723000.0 (Q1 2023).